Research
We conduct research on infectious microbiological agents of both clinical and economic importance. This is the only research facility of its kind in the North East of England.
The facility provides the opportunity for scientists to include Hazard Group 3 (HG3) and Specified Animal Pathogen Order Group 3 pathogens in their research.
The facility proved invaluable during the Covid-19 pandemic enabling university researchers and local businesses to carry out crucial research and validation of diagnostics into SARS-CoV-2.
Contact us if you would like to discuss a potential project using HG3 biological agents, we can assist with planning, training and the process for obtaining the necessary permissions from the HSE.
Project request for the Infectious Diseases Facility can be made via PPMS by completing this .
Acknowledging our input
If you've used our Infectious Diseases Facility, please recognise and acknowledge it in your work.
Acknowledging Infectious Diseases Facility in your papers, posters and talks will help to ensure we can continue to provide laboratories with appropriate containment and maintained plant and equipment.
Key Publications
If you've used the Infectious Diseases Facility, please recognise and acknowledge it in your work. Acknowledging the Infectious Diseases Facility in your papers, posters and talks will help to ensure we can continue to provide laboratories with appropriate containment, maintained plant and equipment.
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 C. F. Hatton, R. A. Botting, M. E. Due帽as, I. J. Haq, B. Verdon, B. J. Thompson, et al.
Conjunctival epithelial cells resist productive SARS-CoV-2 infection R. M. Jackson, C. F. Hatton, J. S. Spegarova, M. Georgiou, J. Collin, E. Stephenson, et al.